Eligible ages
Adults 18+
Compensation
Up to $5,735 for time and effort
Who is eligible
• Are at least 18 years of age • Have a BMI of 30 kg/m² or higher, or at least 27 kg/m² with a weight-related health condition • Are currently taking an incretin-based GLP-1 medication such as semaglutide or tirzepatide (must be Ozempic, Mounjaro, Wegovy or Zepbound) • Have been on stable incretin therapy for at least 90 days • Have had relatively stable body weight for at least 90 days Additional criteria may apply. A full list of study criteria will be reviewed with you by our team.
What's involved
Qualified participants may receive: • Access to study medications • Study-related care at no cost • Compensation up for time and travel • The opportunity to help advance potential new options for reducing body weight Participation is voluntary, and health insurance is not required.
Where this study is run
ALSA Research – Bridgeport
4641 Main Street, Suite 3, Bridgeport, CT 06606